Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases

被引：1
作者：
Dionisi, Valeria [1 ,2 ]
Bellarosa, Chiara [1 ,2 ]
Cardano, Raffaele [1 ,2 ]
Rizzini, Elisa Lodi [2 ,3 ]
Ghedini, Pietro [2 ,3 ]
Morganti, Alessio Giuseppe [1 ,2 ]
Fanti, Stefano [2 ,3 ]
Monari, Fabio [1 ]
机构：
[1] St Orsola Marcello Malpighi Hosp, Radiat Oncol Ctr, Via Giuseppe Massarenti 9, I-40138 Bologna, Italy
[2] DIMES Univ Bologna, Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Nudear Med, Bologna, Italy
来源：
CLINICAL GENITOURINARY CANCER | 2019年 / 17卷 / 03期
关键词：
Bisphosphonate therapy; Bone metastases; Castration-resistant prostate cancer; Jaw necrosis; Ra-223; BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; BONE METASTASES; ANDROGEN DEPRIVATION; PROSTATE-CANCER; AMERICAN ASSOCIATION; SKELETAL METASTASES; RISK-FACTORS; MULTICENTER; FRACTURE;
D O I：
10.1016/j.clgc.2019.03.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E612 / E617
页数：6
相关论文
共 28 条
[1]   Higher Bone Matrix Density Exists in Only a Subset of Patients With Bisphosphonate-Related Osteonecrosis of the Jaw [J].
Allen, Matthew R. ;
Ruggiero, Salvatore L. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (07) :1373-1377
[2]   Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy [J].
Berruti, A ;
Dogliotti, L ;
Terrone, C ;
Cerutti, S ;
Isaia, G ;
Tarabuzzi, R ;
Reimondo, G ;
Mari, M ;
Ardissone, P ;
De Luca, S ;
Fasolis, G ;
Fontana, D ;
Rossetti, SR ;
Angeli, A .
JOURNAL OF UROLOGY, 2002, 167 (06) :2361-2367
[3]   High-linear energy transfer irradiation targeted to skeletal metastases by the α-emitter 223Ra:: Adjuvant or alternative to conventional modalities? [J].
Bruland, Oyvind S. ;
Nilsson, Sten ;
Fisher, Darrell R. ;
Larsen, Roy H. .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6250S-6257S
[4]   EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer [J].
Cornford, Philip ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Briers, Erik ;
De Santis, Maria ;
Gross, Tobias ;
Henry, Ann M. ;
Joniau, Steven ;
Lam, Thomas B. ;
Mason, Malcolm D. ;
van der Poel, Henk G. ;
van der Kwast, Theo H. ;
Rouviere, Olivier ;
Wiegel, Thomas ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2017, 71 (04) :630-642
[5]   Progressive osteoporosis during androgen deprivation therapy for prostate cancer [J].
Daniell, HW ;
Dunn, SR ;
Ferguson, DW ;
Lomas, G ;
Niazi, Z ;
Stratte, PT .
JOURNAL OF UROLOGY, 2000, 163 (01) :181-186
[6]   Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer [J].
El-Amm, Joelle ;
Aragon-Ching, Jeanny B. .
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 :11-19
[7]  
European Medicines Agency (EMA), 2018, XOF RAD RA223 DICHL
[8]   Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series [J].
Fedele, Stefano ;
Porter, Stephen R. ;
D'Aiuto, Francesco ;
Aljohani, Suad ;
Vescovi, Paolo ;
Manfredi, Maddalena ;
Arduino, Paolo G. ;
Broccoletti, Roberto ;
Musciotto, Anna ;
Di Fede, Olga ;
Lazarovici, Tony S. ;
Campisi, Giuseppina ;
Yarom, Naom .
AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11) :1060-1064
[9]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100
[10]  
Henriksen G, 2002, CANCER RES, V62, P3120
123